Patient Association: International Neuroendocrine Cancer Alliance (European Union): Difference between revisions
From Beacon
(Created page with "{{forpatients}} Go back to European Union page '''Primary purpose:''' To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumors (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care. '''Cancer areas of interest:''' hasCancerType::C15-C26: Digestive system cancers, hasCancerType::C30-C39: Lung/chest cancers and hasCanc...") |
No edit summary |
||
| Line 2: | Line 2: | ||
Go back to [[European Union]] page | Go back to [[European Union]] page | ||
'''Primary purpose:''' To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine | '''Primary purpose:''' To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumours (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care. | ||
'''Cancer areas of interest:''' [[hasCancerType::C15-C26: Digestive system cancers]], [[hasCancerType::C30-C39: Lung/chest cancers]] and [[hasCancerType::C73-C75: Thyroid and other gland cancers]]. | '''Cancer areas of interest:''' [[hasCancerType::C15-C26: Digestive system cancers]], [[hasCancerType::C30-C39: Lung/chest cancers]] and [[hasCancerType::C73-C75: Thyroid and other gland cancers]]. | ||
'''Access to information:''' [https://incalliance.org/ Click here to access]. | '''Access to information:''' [https://incalliance.org/ Click here to access]. | ||
Revision as of 09:50, 28 August 2024
Go back to European Union page
Primary purpose: To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumours (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care.
Cancer areas of interest: C15-C26: Digestive system cancers, C30-C39: Lung/chest cancers and C73-C75: Thyroid and other gland cancers.
Access to information: Click here to access.
